These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 25063192

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E, del Barrio A, García Ruiz PJ, Pernaute RS, Benítez J, Barroso A, Jiménez FJ, García Yébenes J.
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
    Johnson EB, Parker CS, Scahill RI, Gregory S, Papoutsi M, Zeun P, Osborne-Crowley K, Lowe J, Nair A, Estevez-Fraga C, Fayer K, Rees G, Zhang H, Tabrizi SJ, HD-YAS Investigators.
    EBioMedicine; 2021 Mar; 65():103266. PubMed ID: 33706250
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Listener Detection of Objectively Validated Acoustic Features of Speech in Huntington's Disease.
    Chan JCS, Stout JC, Shirbin CA, Vogel AP.
    J Huntingtons Dis; 2022 Mar; 11(1):71-79. PubMed ID: 34974436
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W, Silva HB, Real J, Wang YM, Rial D, Li P, Payen MP, Zhou Y, Muller CE, Tomé AR, Cunha RA, Chen JF.
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [Abstract] [Full Text] [Related]

  • 73. Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.
    Wolf RC, Thomann PA, Sambataro F, Wolf ND, Vasic N, Landwehrmeyer GB, Süßmuth SD, Orth M.
    J Neurol; 2015 Jul; 262(4):859-69. PubMed ID: 25626721
    [Abstract] [Full Text] [Related]

  • 74. Postural deficits in Huntington's disease when performing motor skills involved in daily living.
    Panzera R, Salomonczyk D, Pirogovosky E, Simmons R, Goldstein J, Corey-Bloom J, Gilbert PE.
    Gait Posture; 2011 Mar; 33(3):457-61. PubMed ID: 21256027
    [Abstract] [Full Text] [Related]

  • 75. Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease.
    Labuschagne I, Jones R, Callaghan J, Whitehead D, Dumas EM, Say MJ, Hart EP, Justo D, Coleman A, Dar Santos RC, Frost C, Craufurd D, Tabrizi SJ, Stout JC, TRACK-HD Investigators.
    Psychiatry Res; 2013 May 15; 207(1-2):118-26. PubMed ID: 23051887
    [Abstract] [Full Text] [Related]

  • 76. Do I misconstrue? Sarcasm detection, emotion recognition, and theory of mind in Huntington disease.
    Larsen IU, Vinther-Jensen T, Gade A, Nielsen JE, Vogel A.
    Neuropsychology; 2016 Feb 15; 30(2):181-9. PubMed ID: 26301773
    [Abstract] [Full Text] [Related]

  • 77. Structural and functional changes of the visual cortex in early Huntington's disease.
    Coppen EM, Grond JV, Hafkemeijer A, Barkey Wolf JJH, Roos RAC.
    Hum Brain Mapp; 2018 Dec 15; 39(12):4776-4786. PubMed ID: 30144208
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory.
    Harris KL, Armstrong M, Swain R, Erzinclioglu S, Das T, Burgess N, Barker RA, Mason SL.
    Cortex; 2019 Oct 15; 119():417-427. PubMed ID: 31499434
    [Abstract] [Full Text] [Related]

  • 80. The Repeatable Battery for the Assessment of Neuropsychological Status, While Useful for Measuring Cognitive Changes in Manifest Huntington Disease, May Show Limited Utility in Premanifest Disease.
    Mustafa AI, Corey-Bloom J, Beltran-Najera I, Snell C, Castleton J, Smith H, Gilbert PE.
    Cogn Behav Neurol; 2022 Sep 01; 35(3):198-203. PubMed ID: 35830248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.